1. A method for the treatment of progressive tendency of resistance to successive courses of treatment of T cell lymphoma in a patient comprising: selecting a patient with T-cell lymphoma, where the patient has undergone at least one prior treatment of T-cell lymphoma, wherein at least one previous treatment includes treatment without application of a 10-propargyl-10-deazaaminopterina and administering to the patient a composition comprising a therapeutically effective amount of 10-propargyl-10-deazaaminopterina ensuring reversing of progressive rezistentnosti.2. A method according to claim 1, characterized in that the reference trend progressive resistance to consecutive courses of treatment of T cell lymphoma in a patient is measured as an increase in the number of days the patient progression-free survival in the treatment of a composition containing 10-propargyl-10-deazaaminopterin, compared with number of days the patient progression-free survival when the immediately preceding treatment without application of a 10-propargyl-10-deazaaminopterina.3. The method of claim 1, wherein the 10-propargyl-10-deazaaminopterin substantially free of 10-deazaaminopterina.4. The method of claim 1, wherein the T cell lymphoma is peripheral T cell limfomu.5. A method according to claim 1, characterized in that the T-cell lymphoma is T-cell lymphoma kozhi.6. A method according to claim 1, characterized in that the T-cell lymphoma is T-cell subcutaneous pannikulitopodobnuyu limfomu.7. A method according to claim 1, characterized in that the T-cell lymphoma is a1. Способ обращения тенденции развития прогрессирующей резистентности к последовательным курсам лечения Т-клеточной лимфомы у пациента, включающий: выбор пациента с Т-клеточной лимфомой, где пациент прошел по меньшей мере один предшествующий курс лечения Т-клеточной лимфомы, причем по меньшей мере один предшествующий курс лечения включает лечение без применения 10-пропаргил-10-деазааминоптерина и введение пациенту композици
